Loss of caveolin-1 (CAV-1) is a characteristic feature of breast cancer CAFs, resulting in increased aerobic glycolysis and gain of a myofibroblastic phenotype [84,85,86]. This evidence concerns the gene CAV1 and breast carcinoma.